HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

RMD

ResMed Inc. (S&P 500)

Healthcare — Medical Instruments & Supplies

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Buy 2.4 / 5 15 analysts
$208.96
+$5.88 (+2.90%)
Target: $248.60 (19.0%)
Sign in to add RMD to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$30.31B
P/E Ratio (TTM)20.13
Forward P/E17.30
EPS (TTM)$10.38
Dividend Yield1.18%
Profit Margin27.44%
Revenue Growth10.80%
ROE25.25%
Debt/Equity12.99
Recommendation Buy 2.4
Analyst Target$248.60
Analysts15
Indexes S&P 500

Technical Indicators

RSI (14)52.8
Beta0.78
SMA 20$202.01
SMA 40$197.31
52-Week High$293.81
52-Week Low$180.27
50-Day Avg$198.69
200-Day Avg$233.32
Avg Volume$1.56M
Volume967.1K

Performance Analysis

BULLISH

RMD shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 25% of its 52-week range.
~ RSI at 52.8 is in neutral territory.
~ Modest revenue growth of 10.8% year-over-year.
+ Healthy profit margin of 27.4%.
+ Wall Street consensus is "Buy" from 15 analysts.
+ Average analyst target of $248.60 implies 19.0% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 28, 2026 21:01 UTC

Back to Screener Export Report